On the other hand, abundant tumor-infiltrating lymphocytes and the absence of lymphovascular invasion were found to be favorable, independent prognostic factors for disease free survival (DFS) in patients with HR−/HER2+ breast cancer9. This evidence concerns the gene ERBB2 and neoplasm.